Влияние коморбидных заболеваний на хроническую обструктивную болезнь легких (обзор литературы)
DOI:
https://doi.org/10.52692/1857-0011.2021.3-71.46Ключевые слова:
сопутствующие заболевания, хроническая обструктивная болезнь легкихАннотация
Хроническая обструктивная болезнь легких (ХОБЛ) является основной причиной заболеваемости и смертности во всем мире. Мультиморбидность - это наличие у человека двух или более хронических состояний одновременно. Мультиморбидность часто встречается у пациентов с ХОБЛ и является изменяемым ключевым фактором,который требует своевременного выявления и целостных стратегий ведения, направленных на улучшение результатов и снижение бремени болезни. Диагностика и оценка степени тяжести ХОБЛ могут быть затруднены приналичии сопутствующих заболеваний.Число и тяжесть сопутствующих заболеваний увеличивается с возрастомпациента и существенно влияет на качество жизни, госпитализацию и смертность.
В этом обзоре литературы представлен обзор влияния сопутствующих заболеваний на хроническую обструктивную болезнь легких.
Библиографические ссылки
Corlateanu, A., N. Siafakas, and V. Botnaru, Defining COPD: from simplistic approach to multilateral assessment of COPD. Current Respiratory Care Reports, 2012. 1(3): p. 177-182.
Vogelmeier, C.F., et al., Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med, 2017. 195(5): p. 557-582.
Corlăţeanu, A., et al., From smoking to COPD--current approaches. Pneumologia, 2016. 65(1): p. 20-3.
Lamprecht, B., et al., COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest, 2011. 139(4): p. 752-763.
Gut-Gobert, C., et al., Women and COPD: do we need more evidence? European Respiratory Review, 2019. 28(151): p. 180055.
Corlateanu, A., et al., Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.Respir Investig, 2016. 54(6): p. 387-396.
Agusti, A., Thomas a. Neff lecture. Chronic obstructive pulmonary disease: a systemic disease. Proc Am Thorac Soc, 2006. 3(6): p. 478-81.
Casaburi, R., Skeletal muscle function in COPD. Chest, 2000. 117(5 Suppl 1): p. 267S-71S.
Morley, J.E., D.R. Thomas, and M.M. Wilson, Cachexia: pathophysiology and clinical relevance. Am J Clin Nutr, 2006. 83(4): p. 735-43.
Sin, D.D. and S.F. Man, Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality. Proc Am Thorac Soc, 2005. 2(1): p. 8-11.
Chaouat, A., R. Naeije, and E. Weitzenblum, Pulmonary hypertension in COPD. Eur Respir J, 2008. 32(5):p. 1371-85.
Mallia, P. and S.L. Johnston, How viral infections cause exacerbation of airway diseases. Chest, 2006.130(4): p. 1203-10.
Bolton, C.E., et al., Associated loss of fat-free mass and bone mineral density in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2004. 170(12): p. 1286-93.
Brody, J.S. and A. Spira, State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc Am Thorac Soc, 2006. 3(6): p. 535-7.
Sarkar, M., P.N. Rajta, and J. Khatana, Anemia in Chronic obstructive pulmonary disease: Prevalence, pathogenesis, and potential impact. Lung India, 2015. 32(2): p. 142-51.
Soler, X., et al., High Prevalence of Obstructive Sleep Apnea in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc, 2015. 12(8): p. 1219-25.
Martinez-Garcia, M.A. and M. Miravitlles, Bronchiectasis in COPD patients: more than a comorbidity? Int J Chron Obstruct Pulmon Dis, 2017. 12: p. 1401-1411.
Yohannes, A.M. and G.S. Alexopoulos, Depression and anxiety in patients with COPD. Eur Respir Rev,2014. 23(133): p. 345-9.
Agusti, A. and J.B. Soriano, COPD as a systemic disease. COPD, 2008. 5(2): p. 133-8.
Steuten, L.M., et al., COPD as a multicomponent disease: inventory of dyspnoea, underweight, obesity and fat free mass depletion in primary care. Prim Care Respir J, 2006. 15(2): p. 84-91.
Yanbaeva, D.G., et al., Systemic effects of smoking. Chest, 2007. 131(5): p. 1557-66.22. Sinden, N.J. and R.A. Stockley, Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities. Ther Adv Chronic Dis, 2010. 1(2): p. 43-57.
Sin, D.D., L. Wu, and S.F. Man, The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest, 2005. 127(6): p. 1952-9.
Van Remoortel, H., et al., Risk factors and comorbidities in the preclinical stages of chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2014. 189(1):p. 30-8.
Barnett, K., et al., Epidemiology of multimorbidityand implications for health care, research, and medical education: a cross-sectional study. Lancet, 2012. 380(9836):p. 37-43.
Sullivan, P.W., et al., Obesity, inactivity, and the prevalence of diabetes and diabetes-related cardiovascular comorbidities in the U.S., 2000-2002. Diabetes Care, 2005. 28(7): p. 1599-603.
Gimeno-Santos, E., et al., Determinants and outcomes of physical activity in patients with COPD: a systematic review. Thorax, 2014. 69(8): p. 731-9.
O’Donnell, D.E. and K.A. Webb, The major limitation to exercise performance in COPD is dynamic hyperinflation. J Appl Physiol (1985), 2008. 105(2): p. 753-5; discussion 755-7.
Cooper, C.B., The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med, 2006. 119(10 Suppl 1): p. 21-31.
Mora, S., et al., Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women. JAMA, 2006. 295(12): p. 1412-9.
Ito, K. and P.J. Barnes, COPD as a disease of accelerated lung aging. Chest, 2009. 135(1): p. 173-180.
Savale, L., et al., Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2009. 179(7): p. 566-71.
Uijen, A.A. and E.H. van de Lisdonk, Multimorbidity in primary care: prevalence and trend over the last 20 years. Eur J Gen Pract, 2008. 14 Suppl 1: p. 28-32.
Fortin, M., et al., A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med, 2012. 10(2): p. 142-51.
Sin, D.D., et al., Mortality in COPD: Role of comorbidities. Eur Respir J, 2006. 28(6): p. 1245-57.
Corlateanu, A., et al., Multidimensional indices in the assessment of chronic obstructive pulmonary disease. Respir Med, 2021. 185: p. 106519.
Divo, M., et al., Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 2012. 186(2): p. 155-61.
Загрузки
Опубликован
Выпуск
Раздел
Лицензия
Copyright (c) 2022 Вестник Академии Наук Молдовы. Медицина
Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
